259 related articles for article (PubMed ID: 27488851)
1. Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.
Zhang W; Chen HJ; Wang ZJ; Huang W; Zhang LJ
Eur Radiol; 2017 May; 27(5):2086-2094. PubMed ID: 27488851
[TBL] [Abstract][Full Text] [Related]
2. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
[TBL] [Abstract][Full Text] [Related]
3. Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Evaluation of the Cell Density and Angiogenesis of Cirrhosis-Related Nodules in an Experimental Rat Model: Comparison and Correlation With Dynamic Contrast-Enhanced MRI.
Luo J; Zhou K; Zhang B; Luo N; Bian J
J Magn Reson Imaging; 2020 Mar; 51(3):812-823. PubMed ID: 31245888
[TBL] [Abstract][Full Text] [Related]
4. Assessment of angiogenesis of hepatocellular carcinoma using dynamic contrast enhanced MR and histopathologic correlation in an experimental rat model.
Lee JH; Park MJ; Kim JK; Kim YC; Kim TH; Park MS; Yu JS; Kim KW; Kim YB; Kim SH; Shim W; Kim D; Yun CO; Ahn SH
Hepatogastroenterology; 2014; 61(130):447-52. PubMed ID: 24901159
[TBL] [Abstract][Full Text] [Related]
5. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.
Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ
PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199
[TBL] [Abstract][Full Text] [Related]
9. MR features of regenerative nodules and dysplastic nodules in the cirrhotic liver.
Xu H; Kong X; Xiong Y; Zhang X
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):601-3. PubMed ID: 16463687
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular nodules in liver cirrhosis: MR evaluation.
Lee JM; Choi BI
Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
[TBL] [Abstract][Full Text] [Related]
12. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V
Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230
[TBL] [Abstract][Full Text] [Related]
13. Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials.
Huh J; Ham SJ; Cho YC; Park B; Kim B; Woo CW; Choi Y; Woo DC; Kim KW
BMC Med Imaging; 2019 Nov; 19(1):89. PubMed ID: 31729971
[TBL] [Abstract][Full Text] [Related]
14. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.
Hayashi M; Matsui O; Ueda K; Kawamori Y; Kadoya M; Yoshikawa J; Gabata T; Takashima T; Nonomura A; Nakanuma Y
AJR Am J Roentgenol; 1999 Apr; 172(4):969-76. PubMed ID: 10587130
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
[TBL] [Abstract][Full Text] [Related]
17. The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas.
Yuan SJ; Qiao TK; Qiang JW; Cai SQ; Li RK
J Ovarian Res; 2017 Sep; 10(1):65. PubMed ID: 28950890
[TBL] [Abstract][Full Text] [Related]
18. Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model.
Li JP; Feng GL; Li DQ; Wang HB; Zhao DL; Wan Y; Jiang HJ
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):612-618. PubMed ID: 27919850
[TBL] [Abstract][Full Text] [Related]
19. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
Park MJ; Kim YK; Lee MH; Lee JH
Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.
Muñoz NM; Minhaj AA; Maldonado KL; Kingsley CV; Cortes AC; Taghavi H; Polak U; Mitchell JM; Ensor JE; Bankson JA; Rashid A; Avritscher R
Magn Reson Imaging; 2019 Apr; 57():156-164. PubMed ID: 30465870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
